MLPH is a novel adipogenic factor controlling redox homeostasis to inhibit lipid peroxidation in adipocytes
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Mi-Yeun Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea; Department of Biotechnology, College…. Hauptthemen laut MEDLINE: 3T3-L1 Cells, Adipocytes, Adipogenesis, Homeostasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Korea Institute of Radiological and Medical Sciences.
Abstract (Originalsprache)
Abnormal adipose tissue formation is associated with metabolic disorders such as obesity, diabetes, and liver and cardiovascular diseases. Thus, identifying the novel factors that control adipogenesis is crucial for understanding these conditions and developing targeted treatments. In this study, we identified the melanosome-related factor MLPH as a novel adipogenic factor. MLPH was induced during the adipogenesis of 3T3-L1 cells and human mesenchymal stem cells. Although MLPH did not affect lipid metabolism, such as lipogenesis or lipolysis, adipogenesis was severely impaired by MLPH depletion. We observed that MLPH prevented excess reactive oxygen species (ROS) accumulation and lipid peroxidation during adipogenesis and in mature adipocytes. In addition, increased MLPH expression was observed under cirrhotic conditions in liver cancer cells and its overexpression also reduced ROS and lipid peroxidation. Our findings demonstrate that MLPH is a novel adipogenic factor that maintains redox homeostasis by preventing lipid peroxidation and ROS accumulation, which could lead to metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, South Ko…
- Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.
- Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon, 34113, South…
- Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, South Korea.
- Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea. Electronic address: khleeby@naver.com.
Förderung
- Korea Institute of Radiological and Medical Sciences
Zitieren
APA
Kim, M. Y., Kim, Y. H., Park, E. R., Shin, Y., Kim, G. H., Jeong, J. H., Gu, M. B., Lee, K. H., & Shin, H. J. (2024). MLPH is a novel adipogenic factor controlling redox homeostasis to inhibit lipid peroxidation in adipocytes. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150459
Vancouver
Kim MY, Kim YH, Park ER, Shin Y, Kim GH, Jeong JH, et al. MLPH is a novel adipogenic factor controlling redox homeostasis to inhibit lipid peroxidation in adipocytes. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150459
BibTeX
@article{Kim2024,
author = {Kim, Mi-Yeun and Kim, Yang-Hyun and Park, Eun-Ran and Shin, Yuna and Kim, Geun Hee and Jeong, Jae-Hoon and Gu, Man Bock and Lee, Kee-Ho and Shin, Hyun-Jin},
title = {MLPH is a novel adipogenic factor controlling redox homeostasis to inhibit lipid peroxidation in adipocytes},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150459}
}
EUVIMED